Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: A methodological review

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Moorthy, Vasee S ^a,b   Reed, Zarifah ^b   Smith, Peter G ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; DELTAMETHRIN; FANSIDAR; INSECTICIDE; IRON; MALARIA VACCINE; PROMETHAZINE; RETINOL;

BED NET; BLOOD SMEAR; CAUSE OF DEATH; CHILDHOOD MORTALITY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; ENDEMIC DISEASE; GIEMSA STAIN; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION RISK; LEUKOCYTE COUNT; MALARIA; MALARIA CONTROL; MORTALITY; PEDIATRICS; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; VACCINATION; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION; ANIMAL; BIOASSAY; CHILD; INFANT; METHODOLOGY; MOSQUITO; PARASITEMIA; PARASITOLOGY; TREATMENT OUTCOME;

ANIMALS; CHILD; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; HUMANS; INFANT; MALARIA; MALARIA VACCINES; MOSQUITO CONTROL; PARASITEMIA; PEDIATRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 60849106668     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-23     Document Type: Review

References (54)

1. Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. V Moorthy Z Reed PG Smith, Vaccine 2007 25 5115 5123 10.1016/j.vaccine.2007.01.085 17577487
2. Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. CG Nevill ES Some VO Mung'ala W Mutemi L New K Marsh C Lengeler RW Snow, Trop Med Int Health 1996 1 139 146 8665377
3. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. PL Alonso T Smith JR Schellenberg H Masanja S Mwankusye H Urassa I Bastos de Azevedo J Chongela S Kobero C Menendez, Lancet 1994 344 1175 1181 10.1016/S0140-6736(94)90505-3 7934537
4. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania. CJ Acosta CM Galindo D Schellenberg JJ Aponte E Kahigwa H Urassa JR Schellenberg H Masanja R Hayes AY Kitua F Lwilla H Mshinda C Menendez M Tanner PL Alonso, Trop Med Int Health 1999 4 368 376 10.1046/j.1365-3156.1999.00406.x 10402973
5. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group. F Nosten C Luxemburger DE Kyle WR Ballou J Wittes E Wah T Chongsuphajaisiddhi DM Gordon NJ White JC Sadoff DG Heppner, Lancet 1996 348 701 707 10.1016/S0140-6736(96)04465-0 8806288
6. An efficacy trial of the malaria vaccine SPf66 in Gambian infants - second year of follow-up. KA Bojang SK Obaro U D'Alessandro S Bennett P Langerock GA Targett BM Greenwood, Vaccine 1998 16 62 67 10.1016/S0264-410X(97) 00159-X 9607010
7. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. PL Alonso J Sacarlal JJ Aponte A Leach E Macete J Milman I Mandomando B Spiessens C Guinovart M Espasa Q Bassat P Aide O Ofori-Anyinam MM Navia S Corachan M Ceuppens MC Dubois MA Demoitie F Dubovsky C Menendez N Tornieporth WR Ballou R Thompson J Cohen, Lancet 2004 364 1411 1420 10.1016/S0140-6736(04)17223-1 15488216
8. A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. P Bejon J Mwacharo O Kai T Mwangi P Milligan S Todryk S Keating T Lang B Lowe C Gikonyo C Molyneux G Fegan SC Gilbert N Peshu K Marsh AV Hill, PLoS Clin Trials 2006 1 e29 17053830 10.1371/journal.pctr.0010029
9. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. C Menendez E Kahigwa R Hirt P Vounatsou JJ Aponte F Font CJ Acosta DM Schellenberg CM Galindo J Kimario H Urassa B Brabin TA Smith AY Kitua M Tanner PL Alonso, Lancet 1997 350 844 850 10.1016/S0140-6736(97)04229-3 9310602
10. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. D Schellenberg C Menendez E Kahigwa J Aponte J Vidal M Tanner H Mshinda P Alonso, Lancet 2001 357 1471 1477 10.1016/S0140-6736(00)04643-2 11377597
11. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. JJ Massaga AY Kitua MM Lemnge JA Akida LN Malle AM Ronn TG Theander IC Bygbjerg, Lancet 2003 361 1853 1860 10.1016/S0140-6736(03)13504-0 12788572
12. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. B Cisse C Sokhna D Boulanger J Milet H Ba el K Richardson R Hallett C Sutherland K Simondon F Simondon N Alexander O Gaye G Targett J Lines B Greenwood JF Trape, Lancet 2006 367 659 667 10.1016/S0140-6736(06)68264-0 16503464
13. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobano S Mabunda M DgeDge P Alonso C Menendez, J Infect Dis 2006 194 276 285 10.1086/505431 16826474
14. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana. FP Mockenhaupt K Reither P Zanger F Roepcke I Danquah E Saad P Ziniel SY Dzisi M Frempong P Agana-Nsiire F Amoo-Sakyi R Otchwemah JP Cramer SD Anemana E Dietz U Bienzle, Antimicrob Agents Chemother 2007 51 3273 3281 17638703 10.1128/AAC.00513-07
15. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. R Kobbe C Kreuzberg S Adjei B Thompson I Langefeld PA Thompson HH Abruquah B Kreuels M Ayim W Busch F Marks K Amoah E Opoku CG Meyer O Adjei J May, Clin Infect Dis 2007 45 16 25 10.1086/518575 17554695
16. Long-term protection against carriage of hepatitis B virus after infant vaccination. MA van der Sande P Waight M Mendy P Rayco-Solon P Hutt T Fulford C Doherty SJ McConkey D Jeffries AJ Hall HC Whittle, J Infect Dis 2006 193 1528 1535 10.1086/503433 16652281
17. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. DM Harper EL Franco C Wheeler DG Ferris D Jenkins A Schuind T Zahaf B Innis P Naud NS De Carvalho CM Roteli-Martins J Teixeira MM Blatter AP Korn W Quint G Dubin, Lancet 2004 364 1757 1765 10.1016/S0140-6736(04)17398-4 15541448
18. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. J Eskola T Kilpi A Palmu J Jokinen J Haapakoski E Herva A Takala H Kayhty P Karma R Kohberger G Siber PH Makela, N Engl J Med 2001 344 403 409 10.1056/NEJM200102083440602 11172176
19. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. K Mulholland S Hilton R Adegbola S Usen A Oparaugo C Omosigho M Weber A Palmer G Schneider K Jobe G Lahai S Jaffar O Secka K Lin C Ethevenaux B Greenwood, Lancet 1997 349 1191 1197 10.1016/S0140-6736(96)09267-7 9130939
20. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. D Chandramohan S Owusu-Agyei I Carneiro T Awine K Amponsa-Achiano N Mensah S Jaffar R Baiden A Hodgson F Binka B Greenwood, Bmj 2005 331 727 733 16195288 10.1136/bmj.331.7519. 727
21. MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials-Scientific, regulatory and public health perspectives. VS Moorthy Z Reed PG Smith, Vaccine 2009 27 624 628 10.1016/j.vaccine.2008.11.034 19061928
22. Attributable fraction estimates and case definitions for malaria in endemic areas. T Smith JA Schellenberg R Hayes, Stat Med 1994 13 2345 2358 10.1002/sim.4780132206 7855468
23. Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Cote d'Ivoire. MC Henry SB Assi C Rogier J Dossou-Yovo F Chandre P Guillet P Carnevale, Am J Trop Med Hyg 2005 73 859 864 16282294
24. Clinical case definitions and malaria vaccine efficacy. WO Rogers F Atuguba AR Oduro A Hodgson KA Koram, J Infect Dis 2006 193 467 473 10.1086/499314 16388497
25. Apparent tolerance of Plasmodium falciparum in infants in a highly endemic area. P Vounatsou T Smith AY Kitua PL Alonso M Tanner, Parasitology 2000 120 Pt 1 1 9 10.1017/S0031182099005211 10726260
26. Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya. DJ Terlouw MR Desai KA Wannemuehler SK Kariuki CM Pfeiffer PA Kager YP Shi FO Ter Kuile, Am J Clin Nutr 2004 79 466 472 14985223
27. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. B Genton I Betuela I Felger F Al-Yaman RF Anders A Saul L Rare M Baisor K Lorry GV Brown D Pye DO Irving TA Smith HP Beck MP Alpers, J Infect Dis 2002 185 820 827 10.1086/339342 11920300
28. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. D Coulibaly DA Diallo MA Thera A Dicko AB Guindo AK Kone Y Cissoko S Coulibaly A Djimde K Lyke OK Doumbo CV Plowe, Am J Trop Med Hyg 2002 67 604 610 12518850
29. Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. RW Snow I Bastos de Azevedo BS Lowe EW Kabiru CG Nevill S Mwankusye G Kassiga K Marsh T Teuscher, Acta Trop 1994 57 289 300 10.1016/0001-706X(94)90074-4 7810385
30. Indicators of life-threatening malaria in African children. K Marsh D Forster C Waruiru I Mwangi M Winstanley V Marsh C Newton P Winstanley P Warn N Peshu, N Engl J Med 1995 332 1399 1404 10.1056/NEJM199505253322102 7723795
31. Clinical features and outcome of severe malaria in Gambian children. D Waller S Krishna J Crawley K Miller F Nosten D Chapman FO ter Kuile C Craddock C Berry PA Holloway, Clin Infect Dis 1995 21 577 587 8527547
32. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. RW Snow JA Omumbo B Lowe CS Molyneux JO Obiero A Palmer MW Weber M Pinder B Nahlen C Obonyo C Newbold S Gupta K Marsh, Lancet 1997 349 1650 1654 10.1016/S0140-6736(97)02038-2 9186382
33. Severe malaria in Burkina Faso: influence of age and transmission level on clinical presentation. D Modiano BS Sirima A Sawadogo I Sanou J Pare A Konate F Pagnoni, Am J Trop Med Hyg 1998 59 539 542 9790426
34. Severe falciparum malaria in children: a comparative study of 1990 and 2000 WHO criteria for clinical presentation, prognosis and intensive care in Dakar, Senegal. P Imbert P Gerardin C Rogier AS Ka P Jouvencel V Brousse P Guyon, Trans R Soc Trop Med Hyg 2002 96 278 281 10.1016/S0035-9203(02)90099-4 12174779
35. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. H Reyburn R Mbatia C Drakeley I Carneiro E Mwakasungula O Mwerinde K Saganda J Shao A Kitua R Olomi BM Greenwood CJ Whitty, Bmj 2004 329 1212 15542534 10.1136/bmj.38251.658229.55
36. Manifestation and outcome of severe malaria in children in northern Ghana. FP Mockenhaupt S Ehrhardt J Burkhardt SY Bosomtwe S Laryea SD Anemana RN Otchwemah JP Cramer E Dietz S Gellert U Bienzle, Am J Trop Med Hyg 2004 71 167 172 15306705
37. Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. KE Lyke A Dicko A Kone D Coulibaly A Guindo Y Cissoko K Traore CV Plowe OK Doumbo, Vaccine 2004 22 3169 3174 10.1016/j.vaccine.2004.01.054 15297070
38. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. H Reyburn R Mbatia C Drakeley J Bruce I Carneiro R Olomi J Cox WM Nkya M Lemnge BM Greenwood EM Riley, Jama 2005 293 1461 1470 10.1001/jama.293.12.1461 15784869
39. The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters. CR Newton C Valim S Krishna D Wypij C Olola T Agbenyega TE Taylor, Clin Infect Dis 2005 41 948 957 16142658 10.1086/432941
40. Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. T Taylor C Olola C Valim T Agbenyega P Kremsner S Krishna D Kwiatkowski C Newton M Missinou M Pinder D Wypij, Trans R Soc Trop Med Hyg 2006 100 615 622 16551469 10.1016/j.trstmh.2005.09.021
41. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. EL Korenromp BG Williams E Gouws C Dye RW Snow, Lancet Infect Dis 2003 3 349 358 10.1016/S1473-3099(03)00657-1 12781507
42. A nationally representative case-control study of smoking and death in India. P Jha B Jacob V Gajalakshmi PC Gupta N Dhingra R Kumar DN Sinha RP Dikshit DK Parida R Kamadod J Boreham R Peto, N Engl J Med 2008 358 1137 1147 10.1056/NEJMsa0707719 18272886
43. Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial. FN Binka A Kubaje M Adjuik LA Williams C Lengeler GH Maude GE Armah B Kajihara JH Adiamah PG Smith, Trop Med Int Health 1996 1 147 154 8665378
44. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. U D'Alessandro BO Olaleye W McGuire P Langerock S Bennett MK Aikins MC Thomson MK Cham BA Cham BM Greenwood, Lancet 1995 345 479 483 10.1016/S0140-6736(95)90582-0 7861874
45. Do insecticide-treated curtains reduce all-cause child mortality in Burkina Faso? A Habluetzel DA Diallo F Esposito L Lamizana F Pagnoni C Lengeler C Traore SN Cousens, Trop Med Int Health 1997 2 855 862 10.1046/j.1365-3156. 1997.d01-413.x 9315044
46. Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya. PA Phillips-Howard BL Nahlen MS Kolczak AW Hightower FO ter Kuile JA Alaii JE Gimnig J Arudo JM Vulule A Odhacha SP Kachur E Schoute DH Rosen JD Sexton AJ Oloo WA Hawley, Am J Trop Med Hyg 2003 68 23 29 12749482
47. Impact of permethrin-treated bed nets on the incidence of sick child visits to peripheral health facilities. PA Phillips-Howard BL Nahlen KA Wannemuehler MS Kolczak FO ter Kuile JE Gimnig K Olson JA Alaii A Odhacha JM Vulule WA Hawley, Am J Trop Med Hyg 2003 68 38 43 12749484
48. Malaria Vaccine Technology Roadmap Final Report. 2006 http://www.malariavaccineroadmap.net
49. Safety of the RTS, S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. JJ Aponte P Aide M Renom I Mandomando Q Bassat J Sacarlal MN Manaca S Lafuente A Barbosa A Leach M Lievens J Vekemans B Sigauque MC Dubois MA Demoitie M Sillman B Savarese JG McNeil E Macete WR Ballou J Cohen PL Alonso, Lancet 2007 370 1543 1551 10.1016/S0140-6736(07)61542-6 17949807
50. Intermittent preventive treatment against malaria in infants in Gabon - a randomized, double-blind, placebo-controlled trial. MP Grobusch B Lell NG Schwarz J Gabor J Dornemann M Potschke S Oyakhirome GC Kiessling M Necek MU Langin PK Klouwenberg A Klopfer B Naumann H Altun ST Agnandji J Goesch M Decker CL Salazar C Supan DU Kombila L Borchert KB Koster P Pongratz AA Adegnika I Glasenapp S Issifou PG Kremsner, J Infect Dis 2007 196 1595 1602 10.1086/522160 18008242
51. Maloprim malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania. MM Lemnge HA Msangeni AM Ronn FM Salum PH Jakobsen JI Mhina JA Akida IC Bygbjerg, Trans R Soc Trop Med Hyg 1997 91 68 73 10.1016/S0035-9203(97)90401-6 9093633
52. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. AH Shankar B Genton RD Semba M Baisor J Paino S Tamja T Adiguma L Wu L Rare JM Tielsch MP Alpers KP West Jr, Lancet 1999 354 203 209 10.1016/S0140-6736(98)08293-2 10421302
53. Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. FO ter Kuile DJ Terlouw SK Kariuki PA Phillips-Howard LB Mirel WA Hawley JF Friedman YP Shi MS Kolczak AA Lal JM Vulule BL Nahlen, Am J Trop Med Hyg 2003 68 68 77 12749488
54. Effects of insecticide-treated bednets during early infancy in an African area of intense malaria transmission: a randomized controlled trial. O Muller C Traore B Kouyate Y Ye C Frey B Coulibaly H Becher, Bull World Health Organ 2006 84 120 126 10.2471/BLT.05.023150 16501729